Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

Shabir A. Madhi, Vicky Baillie, Clare L. Cutland, Merryn Voysey, Anthonet L. Koen, Lee Fairlie, Sherman D. Padayachee, Keertan Dheda, Shaun L. Barnabas, Qasim E. Bhorat, Carmen Briner, Gaurav Kwatra, Khatija Ahmed, Parvinder Aley, Sutika Bhikha, Jinal N. Bhiman, As'Ad E. Bhorat, Jeanine Du Plessis, Aliasgar Esmail, Marisa GroenewaldElizea Horne, Shi Hsia Hwa, Aylin Jose, Teresa Lambe, Matt Laubscher, Mookho Malahleha, Masebole Masenya, Mduduzi Masilela, Shakeel McKenzie, Kgaogelo Molapo, Andrew Moultrie, Suzette Oelofse, Faeezah Patel, Sureshnee Pillay, Sarah Rhead, Hylton Rodel, Lindie Rossouw, Carol Taoushanis, Houriiyah Tegally, Asha Thombrayil, Samuel Van Eck, Constantinos K. Wibmer, Nicholas M. Durham, Elizabeth J. Kelly, Tonya L. Villafana, Sarah Gilbert, Andrew J. Pollard, Tulio De Oliveira, Penny L. Moore, Alex Sigal, Alane Izu, Network for Genomic Surveillance in South Africa, Wits VIDA COVID vaccine trial group, Laurelle Jackson

Research output: Contribution to journalArticlepeer-review

908 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant'. Together they form a unique fingerprint.

Immunology and Microbiology

Agricultural and Biological Sciences

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry